News: Infectious Diseases
Read the latest news from the College of Natural Sciences at The University of Texas at Austin
Department of Molecular Biosciences
Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
A COVID-19 vaccine in human trials in Vietnam, Thailand and Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines.
Do Sick Animals Socially Distance?
According to a new review in the journal Science, when highly social animals — such as ants, mice and bats — get sick, their social interactions change...
Department of Molecular Biosciences
Scientists Discover How Remdesivir Works to Inhibit Coronavirus
For the first time, scientists identified a critical mechanism that remdesivir uses against SARS-CoV-2 and unearthed information that drug companies can use to develop new...
UT News
Texas Coronavirus Scientists Win Award for Research with ‘Great Societal Benefit’
The world’s largest multidisciplinary scientific society has announced that Jason McLellan, a University of Texas at Austin associate professor in the Department of Molecular Biosciences...
Coronavirus Mutation May Have Made It More Contagious
The virus that causes COVID-19 is accumulating genetic mutations, one of which may have made it more contagious.
Curbing COVID-19 Hospitalizations Requires Attention to Construction Workers
A new study shows how much more likely construction workers are to get diagnosed with COVID-19 compared to non-construction workers
Ask the COVID-19 Experts
An epidemiologist and two molecular bioscientists get to the bottom of your burning COVID-19 questions.
Some Bacteria Sacrifice Themselves to Protect their Brethren from Antibiotics
Discovery may aid the fight against antibiotic resistance.
Department of Molecular Biosciences
Locking Down Shape-Shifting Spike Protein Aids Development of COVID-19 Vaccine
An experimental COVID-19 vaccine against SARS-CoV-2 elicits neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein.
Department of Molecular Biosciences
COVID-19 Vaccine Innovation Could Dramatically Speed Up Worldwide Production
A redesigned version of the coronavirus spike protein called HexaPro might speed up vaccine production and yield a more effective immune response to SARS-CoV-2.
